Introduction {#sec1-1}
============

The development of colorectal cancer (CRC) is strongly influenced by environmental factors, including lifestyle. Epidemiological studies have shown strong evidence that an excessive intake of alcohol, lean meat and processed meat are CRC risk factors. On the other hand, the intake of food rich in dietary fiber reduces CRC risk (Institute for Cancer Research, USA, 2007). In Japan, a similar positive relationship has been reported between alcohol consumption and CRC risk (Otani et al., 2003; Shimizu et al., 2003; Wakai et al., 2005). In spite of the evidence, the mechanism by which drinking alcohol increases CRC is not fully clarified yet.

In the case of esophageal cancer, acetaldehyde has been shown to be involved in esophageal carcinogenesis (Yokoyama et al., 2005; Yang et al., 2005; Chen et al., 2006; Yang et al., 2007; Matsuo et al., 2001). Alcohol is oxidized to acetaldehyde mainly by alcohol dehydrogenase (ADH), which consists of *ADH1B* and *ADH1C*. Acetaldehyde is further oxidized to acetic acid, mainly by acetaldehyde dehydrogenases (ALDH), such as ALDH2. Certain genetic polymorphisms in *ADH1B* and *ALDH2* genes have been characterized regarding their role in defining the metabolizing capacity of these enzymes (Matsuo et al., 2006; Yokoyama et al., 2001). In the case of CRC, however, many published studies have shown that acetaldehyde is not a contributing factor (Yin et al., 2007; Matsuo et al., 2002; Chen et al., 2015). We reported a case-control study on genetic polymorphisms of two enzymes, ADH1B and ALDH2, which have some influence on the development of colorectal adenoma or intramucosal cancer (Shiotani et al., 2015). In this study, we revealed that drinking alcohol increased the risk of colon tumor development in people with high enzyme activity of ADH1B and ALDH2. However, these results did not demonstrate direct explanation why direct drinking promotes CRC development.

There are several reports suggesting the relationship between bowel movement and CRC development. A positive relationship has been reported for extremely strong constipation and CRC development (Kotake et al., 1995; Le Marchand et al., 1997; Ghadirian et al., 1998; Jacobs et al., 1998; Roberts et al., 2003). In addition, diarrhea is caused by abnormal bowel movement. However, there are few studies investigating the relationship between diarrhea and CRC development. In those reports, it was reported that the risk of CRC tended to be higher in those with diarrhea (Kojima et al., 2004; Otani et al., 2006; Inoue et al., 1995; Kato et al., 1993). It is generally known that diarrhea may occur after drinking. Thus, we hypothesized that diarrhea after drinking may also play an important role in colorectal carcinogenesis; however, to date, no study has been conducted analyzing CRC patients with diarrhea after drinking and probing the correlation between diarrhea after drinking and CRC development.

Herein, with an aim to address this deficiency, we used our previous case-control study (Ishikawa et al., 2005) to investigate the relationship between the colorectal tumor patients with diarrhea after drinking and the probability of colorectal tumor development. We have examined the presence or absence of diarrhea after drinking and further evaluate the correlation of diarrhea after drinking with the incidence of colorectal tumors. Moreover, we analyzed the relation with colon tumor and genetic polymorphisms of alcohol metabolizing enzymes, depending on the presence or absence of diarrhea after drinking.

Materials and Methods {#sec1-2}
=====================

Study design and subjects {#sec2-1}
-------------------------

The subjects in this study were participants in a randomized clinical trial of the administration of wheat bran and *Lactobacillus casei* preparation for the prevention of colorectal tumors. The details of this trial have previously been reported (Ishikawa et al., 2005). Briefly, the participants included 417 male and female patients aged 40 to 65 years who had undergone a total colonoscopy at Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan. The subjects with one or more colorectal tumors (early intramucosal tumors and adenomas) subsequently underwent the endoscopic removal of all tumors, and underwent histopathology. The participants were recruited from June 1993 to September 1997. Subjects for whom the genetic polymorphisms of *ADH1B* and *ALDH2* were not determined and those with missing values in the correction items were excluded, and the remaining 113 were included in the analysis.

Patients with malignant diseases who underwent intestinal resections, except for appendectomy, as well as those with familial adenomatous polyposis or serious diseases were excluded from both groups.

This study was reviewed and approved by the Ethics Committee of Osaka Medical Center for Cancer and Cardiovascular Diseases. Informed consent was obtained from all the participants in the Case Group and Control Group.

Determining the status of the feces {#sec2-2}
-----------------------------------

The participants in the Case Group and Control Group were interviewed to obtain their height, weight, past medical history, medication history, and family history as well as information on diet, drinking, smoking, lifestyle, physical activity, and the use of non-steroidal anti-inflammatory drugs (NSAIDs), such as aspirin. To obtain the status of the feces, a self-recorded questionnaire survey was administered using the dietary-recording method for three consecutive weekdays at the time of entry into the study. In the self-recorded questionnaire, the status of the feces was ascertained according to the following 5 grades: 1) always have diarrhea, 2) sometimes diarrhea, 3) occasionally diarrhea, 4) rarely diarrhea, and 5) do not have diarrhea. For the analysis, 1) and 2) were included into one group "to have diarrhea after drinking" and 3) and 4) to "do not have diarrhea after drinking."

Determining drinking behavior {#sec2-3}
-----------------------------

Alcohol intake was obtained in terms of the grams of alcohol. A self-recorded questionnaire was also used to collect information on drinking behavior, and nutritionists clarified any unclear statements through interviews. In the self-recorded questionnaire, current drinking behavior was ascertained according to the following 6 grades: 1) drink every day, 2) drink approximately 3--5 times per week, 3) drink approximately 1--2 times per week, 4) drink approximately 1--3 times per month, 5) drink approximately 1--10 times per year, and 6) do not drink. In addition, types of liquor (Japanese sake, beer, Shochu, or whiskey) and amount of liquor (how many sake bottles, large beer bottles, or glasses) they drank were asked to calculate the daily alcohol intake (in grams). We categorized the daily amount of alcohol intake into the following 4 groups: non-drinker, light drinker (\<16 g/day), moderate drinker (≥16 but \<35 g/day), and heavy drinker (≥35.0 g/day).

Measurement of genetic polymorphisms {#sec2-4}
------------------------------------

Blood samples were obtained from the subjects. We analyzed the *ALDH2 Glu504Lys* and *ADH1B His48Arg* polymorphisms. Each of the *ADH1B* and *ALDH2* genotypes was determined based on a previously published method (Takeshita et al., 1994; Takeshita et al.,1996). For ALDH2, Glu/Glu was designated as "high", and Glu/Lys and Lys/Lys as "low"; for ADH1B, Arg/His and Arg/Arg as "slow", and His/His as "fast".

Analytical methods {#sec2-5}
------------------

For sex, height, weight and body mass index (BMI), t tests were used for comparison between the Case Group and Control Group. Comparisons between the Case Group and Control Group regarding the amount of alcohol intake, smoking and genotype were performed by calculating the odds ratio (OR) and 95% confidence interval (CI). With regard to the polymorphisms and their combinations in each group, the OR adjusted for age/sex or for age/sex/BMI/smoking and the 95% CI was calculated using a logistic regression model. IBM SPSS Statistics Ver. 20 was used for the statistical analyses. An unpaired t-test was used to compare the background factors between the two groups, and it was regarded as significant with a p value of 5% or less.

Results {#sec1-3}
=======

[Table 1](#T1){ref-type="table"} shows the features of the participants of this study. Men were more frequent in both the Case Group and Control Group. There was a slightly younger trend in the Case Group than the Control Group. There was no difference in height, weight and BMI between the groups. The amount of alcohol consumption was significantly higher in the Case Group. The frequency of genotypes of all polymorphisms was in accordance with Hardy-Weinberg's rule in the Control Group, and the allele frequency was almost consistent with the frequency reported in Japan (Yoshimura et al., 2003).

###### 

Characteristics of the Study Subjects

                          Cases all (n=231)                           Controls (n=186)   OR (95%CI)^[b](#t1f2){ref-type="table-fn"}^
  ----------------------- ------------------------------------------- ------------------ ---------------------------------------------
  \% Male                 83.5                                        78.5               
  Age (yr), mean±SD       56.4±6.4^[a](#t1f1){ref-type="table-fn"}^   58.0±10.0          
  Height (cm), mean±SD    164.6±7.4                                   164.0±8.1          
  Weight (Kg), mean±SD    63.9±9.6                                    66.1±11.0          
  BMI (Kg²), mean±SD      23.5±3.0                                    24.5±3.2           
  Alcohol consumption                                                                    
   Non-drinker (%)        32 (13.9)                                   65 (35.0)          1
   Light drinker (%)      56 (24.2)                                   40 (21.5)          3
   Moderate drinker (%)   61 (26.4)                                   41 (22.0)          3.4
   Heavy drinker (%)      82 (35.5)                                   40 (21.5)          4.6

Significantly different from controls:P\<0.05;

OR, were adjusted for age and sex.

Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"} show the relationship between the presence of diarrhea after drinking and colorectal tumor. Compared with the Control Group, there are more patients with diarrhea after drinking in the Case Group, even in the examinations using all subjects regardless of non-drinkers or heavy drinkers. Odds ratio for all subjects was 2.1 (95% confidence interval, CI: 1.18 - 3.80), and for heavy drinkers was 4.2 (1.48 - 11. 90). Meanwhile, odds ratio for moderate drinkers was 0.99 (0.38-2.57).

###### 

Multivariable-Adjusted Odds Ratio for the Presence of Diarrhea after Drinking and Colorecral Tumor in All Subject Including Non- drinker

                    Diarrhea after drinking                     
  ----------------- ------------------------- ----------- ----- -----------
  control (n=151)   130                       21 (13.9)   1     
  case (n=216)      157                       59 (27.3)   2.1   1.18-3.80

OR were adjusted for age, sex, BMI and smoking status

###### 

Multivariable-Adjusted Odds Ratio for the Presence of Diarrhea after Drinking and Colorecral Tumor in Heavy Drinker

                   Diarrhea after drinking                     
  ---------------- ------------------------- ----------- ----- ------------
  control (n=38)   31                        7 (18.4)    1     
  case (n=75)      42                        33 (44.0)   4.2   1.48-11.90

OR were adjusted for age, sex, BMI and smoking status.

[Table 4](#T4){ref-type="table"} shows the relationship between diarrhea after drinking and genetic polymorphisms of ADH 1 B and ALDH 2 in all subjects, i.e., combined Control and Case Group. The subjects who said diarrhea occurs after drinking mainly harbored ADH 1 B (slow) plus ALDH 2 (high), and the highest ratio was 48.3%, but there was no significant difference.

###### 

Ratio of Presence of Diarrhea after Drinking in a Combination of Alcohol Metabolizing Enzyme Activity in All (Case and Control) Group.

  Combination of alcohol metabolizing enzyme activity   Diarrhea after drinking   OR          95%CI   
  ----------------------------------------------------- ------------------------- ----------- ------- -----------
  ADH1B (slow). ALDH2 (low) (n=13)                      10                        3 (23.1)    1       
  ADH1B (fast). ALDH2 (low) (n=8)                       6                         2 (25.0)    0.7     0.16-2.99
  ADH1B(slow). ALDH2 (high) (n=29)                      15                        14 (48.3)   2.4     0.88-6.52
  ADH1B (fast). ALDH2(high) (n=63)                      42                        21 (33.3)   1.1     0.19-6.20

OR were adjusted for age, sex, BMI and smoking status.

Discussion {#sec1-4}
==========

This study revealed that those who have diarrhea after drinking possess a high risk of developing colon tumors. Involvement of alcohol metabolizing enzymes (ADH1B, ALDH2) plus diarrhea in the development of colon tumors has not been revealed.

Hitherto, many epidemiological studies have demonstrated that alcohol consumption and colorectal cancer have a positive correlation. However, an acceptable explanation has not been presented. There are several reports of case-control studies that shows a relationship between a history of loose stools / diarrhea and a high risk of CRC. However, there have been no studies showing the relationship between the presence of diarrhea after drinking and colon tumors. Our result that diarrhea after drinking increased the risk of CRC implies that diarrhea after drinking may promote colorectal adenoma and CRC development. In animal experiments, increased production of aberrant prostaglandin E2 production along with bowel movement was suggested to promote the development of colon cancer (Burakoff et al., 1992; Yamaguchi et al., 1991; Kawamori et al., 2003).

An advantage of our study is that the results are not caused by a secondary effect of CRC, because the subjects all had a colorectal tumor removed endoscopically or were from a medical examinee for cancer pick-up. Limitations of our study are as follows: (a) this is a case-control study that may not indicate a reliable causal relationship between diarrhea after drinking and a high risk of developing colon tumors, and (b) the number of cases is relatively small.

Hitherto, several reports showing a relationship between diarrhea and CRC risk have been published (Kojima et al., 2004; Otani et al., 2006; Inoue et al., 1995; Kato et al., 1993). Our study could be misunderstood as evaluating the relationship between diarrhea itself and colorectal carcinogenesis. This study showed one of the possibilities that diarrhea caused by alcohol could enhance the risk of CRC. Of course, as the amount of drinking increases, the probability of induction of diarrhea increases. So, it is difficult to evaluate the effects of the amount of drinking or diarrhea itself on colon carcinogenesis separately. Our hypothesis becomes clearer when the risk of CRC increased in the social drinker with frequent diarrhea after drinking alcohol. However, no significant data were obtained due to the small size of this study. On the other hand, we have to clarify how alcohol affects intestinal flora in subjects who suffer diarrhea from alcohol consumption. Moreover, we do not know whether subjects who are susceptible to diarrhea are likely to suffer diarrhea after drinking alcohol or not. Thus, taking all in to consideration, we cannot divide the diarrhea-CRC axis and alcohol-CRC axis clearly at this moment. Although several issues need to be resolved, our study seems to be worthwhile as it pointed out the issue, the relationship between alcohol-induced diarrhea and an increased risk of CRC.

As far as we know, this is the first report that examined genetic polymorphisms of alcohol metabolizing enzymes (ADH1B, ALDH2) and the presence of diarrhea after drinking alcohol. In this study, subjects with a high activity of ALDH2 and with a low activity of ADH1B tended to have diarrhea after drinking alcohol. In these subjects, it was assumed that the subjects could drink a lot because the metabolism of acetaldehyde was fast, and the blood alcohol concentration in the subjects was high because the alcohol metabolism was slow. Thus, high blood alcohol concentration may affect diarrhea induction. To examine this hypothesis, it is necessary to investigate with an increased number of cases in the future.

In our previous report, drinking alcohol significantly increased the risk of colorectal tumors in the two groups ADH 1 B (slow) plus ALDH 2 (low) and ADH 1 B (fast) plus ALDH 2 (high). To these two high-risk groups, instruction to avoid drinking should be provided in the clinic to reduce CRC risk. We also obtained the data that the patients who possess genetic polymorphisms of ADH 1 B (slow) and ALDH 2 (high) plus diarrhea after drinking tended to have more high risk of CRC than other combinations of genetic polymorphisms we tested. Thus, it is recommended to avoid drinking in the patients who possess ADH 1 B (slow) and ALDH 2 (high). To conclude, our hypothesis, however, additional examination is required with more number of cases. We are now planning to use a large-scale clinical trial using aspirin (J-CAPP Study II, UMIN000018734) to reveal the role of genetic polymorphisms and defecation status on colorectal carcinogenesis for 1,200 non-aspirin-administered patients and 7,000 aspirin-administered patients.

In summary, the findings from our study suggest that those who have diarrhea after drinking are suggested to possess a high risk of colon tumors. To elucidate the colon carcinogenesis mechanism by drinking alcohol, further examination is needed to reveal the relationship between drinking and diarrhea.
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